PTEN mRNA translation is negatively regulated by microRNAs

Stable Identifier
R-HSA-8944497
Type
Reaction [omitted]
Species
Homo sapiens
Compartment
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

PTEN protein synthesis is negatively regulated by microRNAs miR-26A1 and miR-26A2, which recruit the RISC complex to PTEN mRNA. Overexpression of miR-26A2, caused by genomic amplification of MIR26A2 locus on chromosome 12, is frequently observed in human brain glioma tumors possessing one wild-type PTEN allele, and is thought to contribute to tumor progression by repressing PTEN protein expression from the remaining allele (Huse et al. 2009). Other microRNAs, which may also be altered in cancer, such as miR-17, miR-19a, miR-19b, miR-20a, miR-20b, miR-21, miR-22, miR-25, miR-93, miR-106a, miR-106b, miR 205, and miR 214, also bind PTEN mRNA and inhibit its translation into protein (Meng et al. 2007, Xiao et al. 2008, Yang et al. 2008, Kim et al. 2010, Poliseno, Salmena, Riccardi et al. 2010, Zhang et al. 2010, Tay et al. 2011, Qu et al. 2012, Cai et al. 2013).

Literature References
PubMed ID Title Journal Year
20223231 MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC)

Zhang, JG, Wang, JJ, Zhao, F, Liu, Q, Jiang, K, Yang, GH

Clin. Chim. Acta 2010
22374676 MiR-205 determines the radioresistance of human nasopharyngeal carcinoma by directly targeting PTEN

Qu, C, Liang, Z, Huang, J, Zhao, R, Su, C, Wang, S, Wang, X, Zhang, R, Lee, MH, Yang, H

Cell Cycle 2012
17681183 MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer

Meng, F, Henson, R, Wehbe-Janek, H, Ghoshal, K, Jacob, ST, Patel, T

Gastroenterology 2007
19487573 The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo

Huse, JT, Brennan, C, Hambardzumyan, D, Wee, B, Pena, J, Rouhanifard, SH, Sohn-Lee, C, le Sage, C, Agami, R, Tuschl, T, Holland, EC

Genes Dev. 2009
18327259 Lymphoproliferative disease and autoimmunity in mice with increased miR-17-92 expression in lymphocytes

Xiao, C, Srinivasan, L, Calado, DP, Patterson, HC, Zhang, B, Wang, J, Henderson, JM, Kutok, JL, Rajewsky, K

Nat. Immunol. 2008
20080666 Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship

Kim, H, Huang, W, Jiang, X, Pennicooke, B, Park, PJ, Johnson, MD

Proc. Natl. Acad. Sci. U.S.A. 2010
22000013 Coding-independent regulation of the tumor suppressor PTEN by competing endogenous mRNAs

Tay, Y, Kats, L, Salmena, L, Weiss, D, Tan, SM, Ala, U, Karreth, F, Poliseno, L, Provero, P, Di Cunto, F, Lieberman, J, Rigoutsos, I, Pandolfi, PP

Cell 2011
23856247 miR-205 targets PTEN and PHLPP2 to augment AKT signaling and drive malignant phenotypes in non-small cell lung cancer

Cai, J, Fang, L, Huang, Y, Li, R, Yuan, J, Yang, Y, Zhu, X, Chen, B, Wu, J, Li, M

Cancer Res. 2013
20388916 Identification of the miR-106b~25 microRNA cluster as a proto-oncogenic PTEN-targeting intron that cooperates with its host gene MCM7 in transformation

Poliseno, L, Salmena, L, Riccardi, L, Fornari, A, Song, MS, Hobbs, RM, Sportoletti, P, Varmeh, S, Egia, A, Fedele, G, Rameh, L, Loda, M, Pandolfi, PP

Sci Signal 2010
18199536 MicroRNA expression profiling in human ovarian cancer: miR-214 induces cell survival and cisplatin resistance by targeting PTEN

Yang, H, Kong, W, He, L, Zhao, JJ, O'Donnell, JD, Wang, J, Wenham, RM, Coppola, D, Kruk, PA, Nicosia, SV, Cheng, JQ

Cancer Res. 2008
Participants
Participant Of
This event is regulated
Authored
Reviewed
Created